Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

<i>PHO5</i> AS elongation affects <i>PHO5</i> gene expression <i>via</i> histone acetylation. by Ana Novačić (8373573)

Comparison of the protein level and fluorescent intensity between EGFP and sfGFP expressed from the <i>C. merolae</i> genome. by Nobuko Sumiya (648113)

Basal transcriptional activities of the upstream region of <i>CMJ101C orf</i> at lower temperatures in the stable transformants. by Nobuko Sumiya (648113)

Duration-dependent effect of 50°C heat shock on the mRNA and protein levels in the stable transformants. by Nobuko Sumiya (648113)

Optimum temperature for heat shock inducible expression in the stable transformants. by Nobuko Sumiya (648113)

Patterns of <i>CMJ101C</i> mRNA induced expression by heat shock. by Nobuko Sumiya (648113)

Change in the levels of <i>GFP</i> mRNA and GFP protein after 1-h 50°C heat shock in the stable transformants. by Nobuko Sumiya (648113)

The association between consistent habitual running or walking and a slow trajectory of estimated GFR decline (quartile 1)^b'*'. by Ronit Calderon-Margalit (584756)

AgrC biotinylation by Agr-ID inhibited the growth of <i>S. aureus</i>. (A) Schematic model for testing the growth of biotinylated <i>S. aureus</i> in LB medium and LB agar plate. (... by Lijuan Qian (3131523)

Impact of DNA extraction process on depth of coverage. by Lizhi Yu (12476136)

Transcriptional activities of the upstream region of <i>CMJ101C orf</i> before and after heat shock treatment in transiently transformed cells. by Nobuko Sumiya (648113)

Relative performance of functional and structural predictors of rate. by Benjamin R. Jack (2637040)

<i>Escherichia coli</i> Cyclopropane Fatty Acid Synthase:  Is a Bound Bicarbonate Ion the Active-Site Base?^† by Fabienne Courtois (2667262)

“…H266A, Y317F, E239A, and E239Q mutants were thus constructed and purified, and their catalytic efficiencies were 5.3, 0.7, 0.2, and <0.02%, respectively. …”

<i>Escherichia coli</i> Cyclopropane Fatty Acid Synthase:  Is a Bound Bicarbonate Ion the Active-Site Base?^† by Fabienne Courtois (2667262)

“…H266A, Y317F, E239A, and E239Q mutants were thus constructed and purified, and their catalytic efficiencies were 5.3, 0.7, 0.2, and <0.02%, respectively. …”

Joint moment data from the lower limb joints. by Eric Yung-Sheng Su (13015474)

Image_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

“…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”

Image_2_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

“…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”